Launch targets $16 billion SGLT-2 inhibitor market that serves 33 million type II diabetics in the US, many of whom are ...

A new study shows that older adults with type 2 diabetes who start treatment with sodium–glucose cotransporter-2 (SGLT-2) ...

(HealthDay News) — For patients with type 2 diabetes, there is an association between glucagon-like peptide-1 receptor agonist (GLP-1 RA) use and chronic cough, according to a study published online ...

A new study shows that older adults with type 2 diabetes who start treatment with sodium–glucose cotransporter-2 (SGLT-2) ...

Wellgistics Health Inc ( ($WGRX) ) has issued an update. On December 8, 2025, Wellgistics Health, Inc. announced the commercial launch of its ...

Women with diabetes can achieve healthy pregnancies with meticulous preparation. Experts emphasize achieving stable blood ...

The risk of sudden cardiac death is higher for people with both type 1 and type 2 diabetes, according to a large study ...

People with either type 1 or type 2 diabetes have a dramatically higher risk of sudden cardiac death, which occurs when the ...

Investing.com -- Wellgistics Health Inc (NASDAQ:WGRX) stock surged 9.2% on Monday after the health information technology company announced the commercial launch of diabetes prescription drug ...

Increased risk "most striking" in younger adults, researchers say ...

A recent study warned that diabetes can significantly increase the risk of sudden cardiac death, when the heart loses its electrical activity.According to a study published in the European Heart ...